Search research articles
Contact Us
Filters
Showing results (11-20 of 66) with videos related to
Page
of 7
Sort By:
International Journal of Molecular Sciences
|
July 24, 2021
Norepinephrine May Oppose Other Neuromodulators to Impact Alzheimer's Disease
Paul J Fitzgerald
Clinical Epidemiology
|
July 19, 2012
Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint
Paul J Fitzgerald
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
July 29, 2024
Frontal Alpha Asymmetry and Its Modulation by Monoaminergic Neurotransmitters in Depression
Paul J Fitzgerald
Neuroscience Letters
|
March 18, 2024
Affective disorders and the loudness dependence of the auditory evoked potential: Serotonin and beyond
Paul J Fitzgerald
International Journal of Molecular Sciences
|
October 13, 2021
Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo
Paul J Fitzgerald
The International Journal of Neuroscience
|
October 18, 2013
Forbearance for fluoxetine: do monoaminergic antidepressants require a number of years to reach maximum therapeutic effect in humans?
Paul J Fitzgerald
Psychiatry Research
|
February 4, 2014
Is elevated norepinephrine an etiological factor in some cases of schizophrenia?
Paul J Fitzgerald
Seizure
|
May 25, 2010
Is elevated norepinephrine an etiological factor in some cases of epilepsy?
Paul J Fitzgerald
Behavioural Brain Research
|
February 21, 2012
The NMDA receptor may participate in widespread suppression of circuit level neural activity, in addition to a similarly prominent role in circuit level activation
Paul J Fitzgerald
Medical Hypotheses
|
March 20, 2012
Neurodrinking: is alcohol a substrate in a novel, endogenous synthetic pathway for norepinephrine?
Paul J Fitzgerald
Page
of 7
Search research articles
Search
Showing results (11-20 of 66) with videos related to
Sort By:
Page
of 7
International Journal of Molecular Sciences
|
July 24, 2021
Norepinephrine May Oppose Other Neuromodulators to Impact Alzheimer's Disease
Paul J Fitzgerald
Clinical Epidemiology
|
July 19, 2012
Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint
Paul J Fitzgerald
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
July 29, 2024
Frontal Alpha Asymmetry and Its Modulation by Monoaminergic Neurotransmitters in Depression
Paul J Fitzgerald
Neuroscience Letters
|
March 18, 2024
Affective disorders and the loudness dependence of the auditory evoked potential: Serotonin and beyond
Paul J Fitzgerald
International Journal of Molecular Sciences
|
October 13, 2021
Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo
Paul J Fitzgerald
The International Journal of Neuroscience
|
October 18, 2013
Forbearance for fluoxetine: do monoaminergic antidepressants require a number of years to reach maximum therapeutic effect in humans?
Paul J Fitzgerald
Psychiatry Research
|
February 4, 2014
Is elevated norepinephrine an etiological factor in some cases of schizophrenia?
Paul J Fitzgerald
Seizure
|
May 25, 2010
Is elevated norepinephrine an etiological factor in some cases of epilepsy?
Paul J Fitzgerald
Behavioural Brain Research
|
February 21, 2012
The NMDA receptor may participate in widespread suppression of circuit level neural activity, in addition to a similarly prominent role in circuit level activation
Paul J Fitzgerald
Medical Hypotheses
|
March 20, 2012
Neurodrinking: is alcohol a substrate in a novel, endogenous synthetic pathway for norepinephrine?
Paul J Fitzgerald
Page
of 7